U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07761936) titled 'Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fluctuations' on April 30.
Brief Summary: This is a Phase III, single-center, randomized, double-blind, placebo-controlled clinical trial designed to investigate the superiority of safinamide compared to a placebo in reducing Parkinson's Disease (PD)-related pain.
The trial plans to enroll 60 adult patients diagnosed with PD who experience motor fluctuations and chronic pain (lasting more than 3 months) despite receiving stable doses of levodopa.
Participants will be randomized in a 1:1 ratio to receive either oral safinamide or a matching placebo as an ...